tetano
Editor, Senior Moderator
PLoS One. 2015 Mar 27;10(3):e0098716. doi: 10.1371/journal.pone.0098716. eCollection 2015.
[h=1]Suboptimal effectiveness of the 2011-2012 seasonal influenza vaccine in adult korean populations.[/h] Choi WS[SUP]1[/SUP], Noh JY[SUP]1[/SUP], Baek JH[SUP]2[/SUP], Seo YB[SUP]3[/SUP], Lee J[SUP]3[/SUP], Song JY[SUP]1[/SUP], Park DW[SUP]1[/SUP], Lee JS[SUP]2[/SUP], Cheong HJ[SUP]1[/SUP], Kim WJ[SUP]4[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] The effectiveness of the 2011-2012 seasonal influenza vaccine was evaluated in adult Korean populations with regard to how well it could prevent laboratory-confirmed influenza and influenza-related complications.
[h=4]MATERIALS AND METHODS:[/h] A retrospective case-control and retrospective cohort study was conducted among patients who visited four selected hospitals from September 2011 to May 2012. The analysis included 1,130 laboratory-confirmed influenza patients. For each influenza case, one control patient was chosen at a ratio of 1:1. A control was defined as an age group-matched patient who visited the same hospital with influenza-like illness within 48 hours of symptom onset but for whom laboratory tests were negative for influenza. Age group and visit date were matched between the cases and controls. Vaccine effectiveness (VE) was defined as [100 ? (1-odds ratio for influenza in vaccinated versus non-vaccinated persons)]. The patients with laboratory-confirmed influenza were followed for at least one month through reviewing the medical records and conducting a telephone interview.
[h=4]RESULTS:[/h] The VE of the 2011-2012 seasonal influenza vaccine was 3.8% [95% confidence interval (CI), -16.5% to 20.6%] for preventing laboratory-confirmed influenza, -16.1% (95% CI, -48.3 to 9.1) for influenza A and 26.2% (95% CI, -2.6 to 46.2) for influenza B. The age-specific adjusted VE was 0.3% (95% CI, -29.4 to 23.1) among participants aged 19 to 49 years, 11.9% (95% CI, -34.3 to 42.2) among those aged 50 to 64 years and -3.9% (-60.1 to 32.5) among those aged ≥65 years. The adjusted VE for preventing any influenza-related complications was -10.7% (95% CI, -41.1% to 42.2%).
[h=4]CONCLUSIONS:[/h] The 2011-2012 seasonal influenza vaccine was not effective in preventing laboratory-confirmed influenza or influenza-related complications in adult Korean populations.
PMID: 25815717 [PubMed - in process] Free full text
[h=1]Suboptimal effectiveness of the 2011-2012 seasonal influenza vaccine in adult korean populations.[/h] Choi WS[SUP]1[/SUP], Noh JY[SUP]1[/SUP], Baek JH[SUP]2[/SUP], Seo YB[SUP]3[/SUP], Lee J[SUP]3[/SUP], Song JY[SUP]1[/SUP], Park DW[SUP]1[/SUP], Lee JS[SUP]2[/SUP], Cheong HJ[SUP]1[/SUP], Kim WJ[SUP]4[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] The effectiveness of the 2011-2012 seasonal influenza vaccine was evaluated in adult Korean populations with regard to how well it could prevent laboratory-confirmed influenza and influenza-related complications.
[h=4]MATERIALS AND METHODS:[/h] A retrospective case-control and retrospective cohort study was conducted among patients who visited four selected hospitals from September 2011 to May 2012. The analysis included 1,130 laboratory-confirmed influenza patients. For each influenza case, one control patient was chosen at a ratio of 1:1. A control was defined as an age group-matched patient who visited the same hospital with influenza-like illness within 48 hours of symptom onset but for whom laboratory tests were negative for influenza. Age group and visit date were matched between the cases and controls. Vaccine effectiveness (VE) was defined as [100 ? (1-odds ratio for influenza in vaccinated versus non-vaccinated persons)]. The patients with laboratory-confirmed influenza were followed for at least one month through reviewing the medical records and conducting a telephone interview.
[h=4]RESULTS:[/h] The VE of the 2011-2012 seasonal influenza vaccine was 3.8% [95% confidence interval (CI), -16.5% to 20.6%] for preventing laboratory-confirmed influenza, -16.1% (95% CI, -48.3 to 9.1) for influenza A and 26.2% (95% CI, -2.6 to 46.2) for influenza B. The age-specific adjusted VE was 0.3% (95% CI, -29.4 to 23.1) among participants aged 19 to 49 years, 11.9% (95% CI, -34.3 to 42.2) among those aged 50 to 64 years and -3.9% (-60.1 to 32.5) among those aged ≥65 years. The adjusted VE for preventing any influenza-related complications was -10.7% (95% CI, -41.1% to 42.2%).
[h=4]CONCLUSIONS:[/h] The 2011-2012 seasonal influenza vaccine was not effective in preventing laboratory-confirmed influenza or influenza-related complications in adult Korean populations.
PMID: 25815717 [PubMed - in process] Free full text